Thus, the PAX5-JAK2 fusion protein functions as a dual-hit mutation to promote B-ALL with a short latency and high penetrance, and does not require a cooperating second event for the full transformation of the preleukemic clone. Here, PAX5 is linked to acute lymphoblastic leukemia.